Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells

Francesco Caiazza, Alyson Murray, Stephen F. Madden, Naoise C. Synnott, Elizabeth J. Ryan, Norma O'Donovan, John Crown, Michael J. Duffy

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells'. Together they form a unique fingerprint.

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience